Holobiome Patents

Patent portfolio assigned to Holobiome (verified via public assignee records). Microbiome platform (Northeastern spinout) building 'Microbiome Vault', targeting gut-brain axis; lead asset next-gen probiotic for depression. Patents confirmed under assignee 'Holobiome Inc' on Google Patents (e.g. EP3429604A1, AU2017234120A1 — gut-microbiome/CNS modulation). Named partners J&J, Unilever, Ingredion (research collaborations); exact count not visible so estimate left 0.